Strategies for Organoid Tissue Dissociation in Single Cell Multi-Omics

18.03.2026

7’

Strategies for Organoid Tissue Dissociation in Single Cell Multi-Omics

Organoids have rapidly become a cornerstone of modern biomedical research. By recapitulating the architectural complexity and cellular diversity of human organs, these three-dimensional in vitro models provide a more physiologically relevant system than traditional 2D cultures or animal models. However, the very complexity that makes organoids so valuable also creates a significant technical hurdle: the transition from a 3D structure to a high-quality single cell suspension. Organoid tissue dissociation is arguably among the most critical steps in a single cell RNA sequencing (scRNA-seq) workflow. A poorly optimized protocol doesn’t just lower cell yield; it can fundamentally skew your results by inducing stress-related gene expression or selectively losing fragile cell populations.

Different organoid cultures require different dissociation protocols

There is no universal dissociation protocol that works on all organoids. The optimal conditions vary depending on the specific organoid type and its structural properties, even on its age.

Brain organoids often contain highly fragile neurons that are susceptible to mechanical shear. Gentle manual processing is often preferred over automated methods to preserve cellular integrity.
Cardiac organoids tend to be dense and may contain necrotic cores as they mature that require careful enzymatic digestion.
Digestive track/stomach organoids have a tendency to agglomerate and may require slightly longer incubation.

Keep those tissue-specific properties in mind to achieve complete digestion, high viability, and a true single cell suspension to start off your single cell sequencing experiment.

Our in-house expertise on organoid tissue dissociation

With hundreds of organoid samples processed in-house in our service laboratories, our staff has extensive experience with various types of organoids. Most frequent organoid types are listed below. Each of these tissue types presents its unique properties and challenges.

Hepatobiliary and pancreatic organoids
Umbilical cord mesenchymal stem cell culture
Stomach and intestinal digestive tract
Olfactory epithelial organoid
Brain organoids
Human embryonic stem cell-derived organoids (cell spheroids)
Heart/vascular organoids
Placental organoids
Kidney organoids

Adipose stem cell culture
Endometrial organoids
Organoids from mouse PDO model
Skin, melanoma
Spinal organoids
Thymoma organoids
Cartilaginous organoids
Retinal organoids
Synovial carcinoma organoids
Breast cancer organoids
Peritoneal cancer organoids

Harvesting timing and conditions are essential to avoid necrotic cores

Avoid harvesting your organoids too late in their developmental cycle. During growth and aging of the organoid, the cells differentiate and specialize. At the same time the organoid increases in size, so that nutrient and oxygen diffusion to the center can become limited, leading to an increase of necrotic cells in the organoid core. (Most cells can only survive within approximately 200–500µm of a nutrient source.) (1)

While overall cell numbers are usually not an issue, viability can become a challenge. One way to improve sample quality is to perform targeted dead cell removal. However, we recommend carefully evaluating the optimal timepoint for sample preparation to ensure the best outcomes. Potential consequences of starvation that would negatively impact your scRNAseq data are:

Hypoxia-induced gene expression: Cells in the organoid center might enter a state of metabolic stress, activating hypoxia-inducible factors (HIFs) and apoptosis-related genes.
Transcriptional artifacts: A stress response would trigger transcriptional noise, where cells express heat-shock proteins and stress-induced markers that do not reflect their true physiological state.
Stunted maturation: The presence of dying cells and toxic metabolic waste (like lactic acid) in the core can physically and chemically inhibit the maturation of surrounding healthy cells, leading to immature or fetal-like models.

Specifically you can look for high levels of HSPA1A and FOS, which usually are dissociation artifacts, caused by too harsh conditions. High HIF1A and VEGFA often are culture artifacts indicating that the organoid has grown too large for its nutrient supply. (2, 3)

The secret to high quality single cell suspensions from organoids

In order to maintain the transcriptional state of a cell after harvesting the organoid, we recommend storing your sample in sCelLiVE™ tissue preservation buffer until further processing. The buffer is designed to maintain high cellular viability through mimicking physiological conditions. At the same time it is worth mentioning that we had good success with organoids sent in their medium and Matrigel.

For particularly sticky samples, such as those derived from the gut or colon, achieving a true single cell suspension can be difficult. If you face clumping, try to supplement your resuspension buffer with 0.4% Bovine Serum Albumin (BSA). That reduces the adhesive properties of the cell membranes, significantly decreasing the rate of doublets and therefore improving the overall quality of the single cell library. (4)

Protocol for organoid tissue dissociation

While your specific dissociation protocol will depend on the tissue type, the following standardized workflow is a good starting point:

Organoid harvesting and ECM removal:

Aspirate the culture medium and wash the organoids 2-3x with 1mL ice-cold, calcium/magnesium-free PBS to remove Matrigel or other extracellular matrices.
Centrifuge at 200g, 5min, 4°C and resuspend in 500µl of 1:1 diluted sCelLiVE^TM tissue dissociation buffer.
Always transfer organoids into low-protein-binding tubes, to avoid loss of material.

Dissociation:

Depending on the organoid size, cut manually into smaller pieces for efficient tissue dissociation.
Use a p200 pipette to break the organoid pellet into smaller clusters (roughly 100–200µm) through vigorously pipetting up and down. This increases the surface area for the enzyme and prevents over-digestion of the outer cells while the inner cells remain clumped.
Incubate in the dissociation solution for 5-15 minutes. For digestive tract organoids (stomach/intestine), which are prone to agglomeration, you should supplement the buffer with 0.4% BSA to reduce stickiness and prevent the formation of doublets.
Every 5 minutes, check the progress under a phase-contrast microscope. You are looking for the transition from large clusters to small clumps of 2–5 cells before proceeding to mechanical dissociation.

Manual vs. automated processing:

Manual trituration: For fragile models like brain organoids, manual pipetting with a wide-bore tip (P1000) is highly recommended to preserve delicate neural structures. Triturate by gently pipetting the suspension up and down 10-20 times.
Automated platforms: For higher throughput or more resilient tissues (like kidney or tumor organoids), automated platforms such as PythoNi or PythoN Jr. can provide standardized results and reduce human error.
Avoid bubbles as interfaces can lyse cells and release genomic DNA leading to cell agglomeration.

Filtration and quality control (QC)

Quench the enzymatic reaction with a stopping buffer (containing serum or inhibitors). Pass the final suspension through a 40µm cell strainer to remove debris and cell clumps.
Dead cell removal: If your viability is below 80%, targeted dead cell removal might be recommended to improve sample quality and reduce ambient RNA noise. However, this will come at a significant loss of cell numbers and therefore, needs to be considered carefully.
Fluorescence QC: While Trypan Blue is common, using AO/PI (Acridine Orange/Propionyl Iodide) fluorescence staining provides a more accurate count by distinguishing live/dead nuclei from debris.

For human kidney organoids, this manual dissociation workflow has consistently achieved >90% viability.

Mastering organoid dissociation is key to revealing gene expression signatures that drive development and disease. By combining tissue-specific knowledge with mild chemical conditions and precise mechanical force, you can generate the high-quality single-cell data required to delineate differentiation paths and uncover new therapeutic targets.

References

McMurtrey, R. J. (2016). “Analytic Models of Oxygen and Nutrient Diffusion, Cellular Metabolism, and Proliferation in Engineered Neural Tissue.” Tissue Engineering Part C: Methods. doi: 10.1089/ten.tec.2015.0375
Denisenko, E., et al. (2020). “Systematic assessment of tissue dissociation and storage biases in single-cell RNA and ATCC-seq.” Nature Communications. doi: 10.1186/s13059-020-02048-6
Kusuma, S., et al. (2018). “Self-organized vascular networks effectively remove metabolic waste and improve health of hPSC-derived organoids.” Nature Communications.
Slyper, M., et al. (2020). “A single-cell and single-nucleus RNA-seq toolbox for fresh and frozen human tumors.” Nature Medicine. doi: 10.1038/s41591-020-0844-1